LON:N4P N4 Pharma (N4P) Share Price, News & Analysis → Elon Musk: THIS will be bigger than Tesla (From Paradigm Press) (Ad) Free N4P Stock Alerts GBX 0.46 -0.06 (-11.43%) (As of 06/14/2024 07:40 PM ET) Add Compare Share Share Today's Range 0.45▼ 0.5050-Day Range 0.47▼ 0.8552-Week Range 0.45▼ 2.10Volume2.06 million shsAverage Volume1.09 million shsMarket Capitalization£1.25 millionP/E RatioN/ADividend Yield3.12%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get N4 Pharma alerts: Email Address Ad Paradigm PressElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you must get in now. Don’t delay.See all the details you need here. About N4 Pharma Stock (LON:N4P)N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.Read More N4P Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart N4P Stock News HeadlinesJune 9, 2024 | americanbankingnews.comN4 Pharma (LON:N4P) Stock Price Down 12%April 26, 2024 | lse.co.ukN4 Pharma strikes partnership deal for intracellular deliveryApril 19, 2024 | lse.co.ukN4 Pharma sees potential in Nuvec delivery method for cancer treatmentJanuary 24, 2024 | lse.co.ukN4 Pharma Plc Share ChatSeptember 28, 2023 | marketwatch.comN4 Pharma Acquires Major Stake in Nanogenics Through Discounted Share Placing; Shares FallJuly 25, 2023 | marketwatch.comN4 Pharma Shares Rise After Further Nuvec Patent Granted in USApril 26, 2023 | marketwatch.comN4 Pharma Shares Rise on Development of Nuvec TestMarch 9, 2023 | marketwatch.comN4 Pharma's Pretax Loss Narrowed in 2022 on Lower R&D CostsFebruary 26, 2023 | seekingalpha.comMicrocap Timber Pharmaceuticals up 46% on orphan drug designation for skin disorder drugJanuary 18, 2023 | marketwatch.comN4 Pharma Shares Rise on Positive Nuvec Oral Application ResultsNovember 1, 2022 | marketwatch.comN4 Pharma Enhances Nuvec's Application Claims in Bid to Gain Patent ProtectionOctober 11, 2022 | finance.yahoo.comInstitutions profited after N4 Pharma Plc's (LON:N4P) market cap rose UK£2.9m last week butindividual investors profited the mostOctober 4, 2022 | marketwatch.comN4 Pharma Shares Rise on Successful Testing of Nuvec, Vaccine SystemSeptember 29, 2022 | marketwatch.comN4 Pharma Narrows 1H Loss by Controlling Expenditure; Shares RiseSeptember 3, 2022 | uk.investing.comFTSE South Africa Technical AnalysisAugust 13, 2022 | finance.yahoo.comN4 Pharma Plc (N4P.L)July 15, 2022 | marketwatch.comN4 Pharma Shares Rise on Further Nuvec ProgressJune 13, 2022 | marketwatch.comN4 Pharma Shares Rise on Positive Results for Nuvec Delivery SystemMarch 31, 2022 | finance.yahoo.comBeroni Group Announces Appointment of Dr. John Chiplin to Board of DirectorsJanuary 31, 2022 | marketwatch.comN4 Pharma Says Nuvec Granted Patents in U.S., ChinaJanuary 25, 2022 | marketwatch.comN4 Pharma to Work on Nuvec With Medicines Discovery Catapult Following Encouraging ResultsDecember 13, 2021 | marketwatch.comN4 Pharma to Focus Resources on Advancing Gene Therapy WorkAugust 30, 2021 | finance.yahoo.comWe Think N4 Pharma (LON:N4P) Can Afford To Drive Business GrowthAugust 24, 2021 | marketwatch.comN4 Pharma Says Nuvec Studies Are Progressing WellSee More Headlines Receive N4P Stock News and Ratings via Email Sign-up to receive the latest news and ratings for N4 Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/17/2020Today6/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolLON:N4P CUSIPN/A CIKN/A Webwww.n4pharma.com Phone+44-1332-690061FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-1,270,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-77.81% Return on Assets-51.74% Debt Debt-to-Equity Ratio1.62 Current Ratio14.86 Quick Ratio7.28 Sales & Book Value Annual Sales£23,524.00 Price / Sales57.13 Cash FlowGBX 0.22 per share Price / Cash Flow2.25 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares268,780,000Free FloatN/AMarket Cap£1.34 million OptionableNot Optionable Beta-0.07 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Nigel James Theobald (Age 60)Founder, CEO & Executive Director Comp: $77.5kDr. David Templeton (Age 72)Executive Director & Technical Director Comp: $46.5kMr. Luke Sebastian Cairns (Age 46)Executive Director Comp: $41.33kRob HarrisHead of CMC DevelopmentDr. Andrew LeishmanConsultantKey CompetitorsHellenic DynamicsLON:HELDHaleonLON:HLNHikma PharmaceuticalsLON:HIKHUTCHMEDLON:HCMIndiviorLON:INDVView All Competitors N4P Stock Analysis - Frequently Asked Questions How have N4P shares performed in 2024? N4 Pharma's stock was trading at GBX 0.85 at the beginning of 2024. Since then, N4P stock has decreased by 45.3% and is now trading at GBX 0.47. View the best growth stocks for 2024 here. How were N4 Pharma's earnings last quarter? N4 Pharma Plc (LON:N4P) announced its earnings results on Thursday, September, 17th. The company reported ($0.48) EPS for the quarter. What other stocks do shareholders of N4 Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other N4 Pharma investors own include Intercede Group (IGP), Medpace (MEDP), Regeneron Pharmaceuticals (REGN), Sirius Minerals (SXX), SolGold (SOLG), Reach (RCH), Petra Diamonds (PDL), Interserve (IRV), Cornerstone Capital Resources (CGP) and Bushveld Minerals (BMN). How do I buy shares of N4 Pharma? Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:N4P) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding N4 Pharma Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share N4 Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.